0000914475-14-000094.txt : 20141215
0000914475-14-000094.hdr.sgml : 20141215
20141215192808
ACCESSION NUMBER: 0000914475-14-000094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141212
FILED AS OF DATE: 20141215
DATE AS OF CHANGE: 20141215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOLLICA JOSEPH A
CENTRAL INDEX KEY: 0001126489
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 141288068
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-12-12
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001126489
MOLLICA JOSEPH A
PO BOX 1182
PRINCETON
NJ
08542
1
0
0
0
Common Stock
2014-12-12
4
M
0
20000
4.76
A
23508
D
Common Stock
2014-12-12
4
F
0
4333
21.97
D
19175
D
Stock Option
4.76
2014-12-12
4
M
0
20000
0
D
2007-06-28
2015-05-28
Common Stock
20000
0
D
The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 28, 2008, which, if unexercised, would have expired on May 28, 2015. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's equity incentive plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($4.76) was subtracted from the December 12, 2014 market close price ($21.97), and this net amount ($17.21) was then multiplied by the number of options (20,000), with the resulting amount then divided by the market close price to result in a net issuance of 15,667 shares to the optionee. The 4,333 shares underlying the remaining portion of the options are not available for reissuance, and no shares are sold into the market as part of the exercise in connection with a net issuance program.
Timothy P. Coughlin, By Power of Attorney
2014-12-15